Digestive Diseases and Sciences

, Volume 57, Issue 4, pp 1110–1111 | Cite as

Hepatorenal Syndrome: Is It the Magnitude of the Renal Failure that Matters?

  • Marco A. Olivera-Martínez
  • Marius C. Florescu


Creatinine Bilirubin Serum Creatinine Creatinine Level Octreotide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Arroyo V, Ginès P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology. 1996;23:164–176.PubMedCrossRefGoogle Scholar
  2. 2.
    Salerno F, Gerbes A, Ginès P, Wong F, Arroyo V. Diagnosis, prevention and treatment of the hepatorenal syndrome in cirrhosis: a consensus workshop of the International Ascites Club. Gut. 2007;56:1310–1318.PubMedGoogle Scholar
  3. 3.
    Olivera-Martínez M, Sayles H, Vivekanandadn R, D’Souza S, Florescu MC. Hepatorenal syndrome: are we missing some prognostic factors? Dig Dis Sci. 2012;57:210–214.Google Scholar
  4. 4.
    Boyer TD, Sanyal AJ, García-Tsao G, et al. Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics. J Hepatol. 2011;55:315–321.PubMedCrossRefGoogle Scholar
  5. 5.
    Martin-Llahi M, Pepin MN, Guevara M, et al. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. Gastroenterology. 2008;134:1352–1359.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Marco A. Olivera-Martínez
    • 1
  • Marius C. Florescu
    • 2
  1. 1.Section of Gastroenterology & Hepatology, Department of Internal MedicineUniversity of Nebraska Medical CenterOmahaUSA
  2. 2.Section of Nephrology, Department of Internal MedicineUniversity of Nebraska Medical CenterOmahaUSA

Personalised recommendations